close
MENU
General Business
2 mins to read

NZ’s biggest pathology group reportedly for sale

Business paid $55m dividend to Australian parent in 2018.

Tim Hunter Fri, 31 Jan 2020

Australian private hospital group Healthscope is understood to be considering a sale or initial public offer for its highly profitable New Zealand pathology business.

Healthscope was itself acquired just six months ago by Canadian investment group Brookfield through its limited partnership

Want to read more? It's easy.

Choose your best value subscription option

Student

Exclusive offer for uni students studying at a New Zealand university (valued at $499).
Individual
Group membership
NBR Marketplace

Yearly Premium Online Subscription

NZ$499.00 / yearly

Monthly Premium Online Subscription

NZ$44.95 / monthly

Smartphone Only Subscription

NZ$24.95 / monthly

Premium Group Membership 10 Users

NZ$350+GST / monthly

$35 per user - Pay by monthly credit card debit

Premium Group Membership 20 Users

NZ$600+GST / monthly

$30 per user - Pay by monthly credit card debit

Premium Group Membership 50 Users

NZ$1250+GST / monthly

$25 per user - Pay by monthly credit card debit

Premium Group Membership 100 Users

NZ$1875+GST / monthly

$18.75 per user - Pay by monthly credit card debit

Yearly Premium Online Subscription + NBR Marketplace

NZ$499.00 / yearly

Already have an account? Login
Tim Hunter Fri, 31 Jan 2020
Contact the Writer: thunter@nbr.co.nz
News tip? Question? Typo? Let us know: editor@nbr.co.nz
© All content copyright NBR. Do not reproduce in any form without permission, even if you have a paid subscription.
NZ’s biggest pathology group reportedly for sale
General Business,
82407
true